BRIEF-FDA approves treatment for metastatic merkel cell carcinoma
March 23, 2017 at 14:28 PM EDT
* Granted accelerated approval to Bavencio for treatment of adults, pediatric patients 12 years and older with metastatic merkel cell carcinoma